Grown Rogue International (GRUSF) Total Current Liabilities (2011 - 2026)

Grown Rogue International's (GRUSF) quarterly Total Current Liabilities came in at $8.3 million in Q1 2026, down 44.11% year-on-year from $14.9 million in Q1 2025, and up 45.0% quarter-over-quarter from $5.7 million in Q4 2025.

Grown Rogue International (GRUSF) Total Current Liabilities (2011 - 2026) Analysis & Trends

Grown Rogue International's Total Current Liabilities history runs 16 years deep, the most recent figure standing at $8.3 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities fell 44.11% year-over-year to $8.3 million in Q1 2026; TTM through Mar 2026 was $8.3 million, a 44.11% decrease from a year earlier, with the FY2025 full-year figure at $5.7 million, down 70.77% from the prior year.
  • Total Current Liabilities improved to $8.3 million in Q1 2026 per GRUSF's latest filing, from $5.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $6658.1 billion in Q3 2025 and bottomed at $5.3 million in Q4 2022.
  • The 5-year median for Total Current Liabilities is $10.8 million (2023), against an average of $475.6 billion.
  • Biggest YoY gain for Total Current Liabilities was 43112177.61% in 2025; the steepest drop was 70.77% in 2025.
  • Year by year, Total Current Liabilities stood at $5.3 million in 2022, then jumped by 62.64% to $8.6 million in 2023, then surged by 126.56% to $19.6 million in 2024, then sank by 70.77% to $5.7 million in 2025, then surged by 45.0% to $8.3 million in 2026.
  • Per Business Quant, the three latest GRUSF Total Current Liabilities figures stand at $8.3 million (Q1 2026), $5.7 million (Q4 2025), and $6658.1 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn 8.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.30 Mn
Dec 31, 2025 5.72 Mn
Sep 30, 2025 6,658.11 Bn
Jun 30, 2025 5.82 Mn
Mar 31, 2025 14.85 Mn
Dec 31, 2024 19.59 Mn
Sep 30, 2024 15.44 Mn
Jun 30, 2024 16.43 Mn
Mar 31, 2024 19.72 Mn
Dec 31, 2023 8.65 Mn
Oct 31, 2023 13.00 Mn
Apr 30, 2023 6.54 Mn
Jan 31, 2023 6.54 Mn
Oct 31, 2022 5.32 Mn
Oct 31, 2021 1.71 Mn
Apr 30, 2021 1.73 Mn
Jan 31, 2021 4.71 Mn
Oct 31, 2020 489,266.00
Jul 31, 2020 2.23 Mn
Jan 31, 2020 4.22 Mn